Skip to main content
. 2022 Mar 17;13:795972. doi: 10.3389/fimmu.2022.795972

Figure 1.

Figure 1

Anti-tumor mechanism of nIT in patients with MSI-H/dMMR CRC. nIT, Neoadjuvant immunotherapy; MSI-H, Microsatellite instability-high; dMMR, Deficient mismatch repair; CRC, Colorectal cancer; TMB, Tumor mutation burden; TNB, Tumor neo-antigen; ORR, Objective response rate; pCR, Pathological complete response.